Panacea Biotec
PANACEABIONSE

Panacea Biotec

₹431.0032.95 (8.28%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
391.00
Today’s high
434.40
52 week low
292.40
52 week high
522.90
Open price
402.50
Previous close
398.05
Live volume
4,19,073
Lower circuit
318.45
Upper circuit
477.65

Fundamentals

Market Cap
₹2,441Cr
ROE
-5.71%
P/E Ratio(TTM)
-257.18
EPS(TTM)
-1.17
P/B Ratio
2.92
Dividend Yield
0.00%
Industry P/E
33.73
Book Value
136.30
Debt to Equity
0.03
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹169
+1.09%
Profit (Cr)
-₹1.00
-125.71%
-50062.5125187.5
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+20%
3Y CAGR-5%
Profit growthValue
1Y (TTM)+99%

About

Panacea Biotec is a premier biotechnology company with over three decades of experience in the development, manufacturing, and commercialization of vaccines and pharmaceutical formulations. Its vision is to become a 'Leading Health Management Company' by creating solutions that meet a wide variety of healthcare needs. Guided by its mission of 'Innovation in Support of Life,' the company focuses on delivering scientific advancements that are both accessible and affordable. The company specializes in innovative vaccines and high-quality generic medicines, committing itself to solving some of the world's most urgent health problems. Beyond pharmaceuticals, the company has expanded into the nutrition sector by launching its own range of in-house developed products for children. With its Easyfive-TT® vaccine, the company has supplied more than 190 million doses to over 75 countries, playing a key role in global immunization.;
CEO/MD
Dr. Rajesh Jain
Founded in
1984
NSE symbol
PANACEABIO

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
72.48%
Retail And Others
23.96%
Other Domestic Institutions
1.96%
Foreign Institutions
1.60%
2026
30
May
Quarterly & Annual Result
Release date
29
May
Result
Release date
11
Feb
Quarterly Result
Release date
2025
14
Nov
Quarterly Result
Release date
14
Aug
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks